Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

45 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
CD73 as a potential opportunity for cancer immunotherapy.
Ghalamfarsa G, Kazemi MH, Raoofi Mohseni S, Masjedi A, Hojjat-Farsangi M, Azizi G, Yousefi M, Jadidi-Niaragh F. Ghalamfarsa G, et al. Among authors: masjedi a. Expert Opin Ther Targets. 2019 Feb;23(2):127-142. doi: 10.1080/14728222.2019.1559829. Epub 2018 Dec 26. Expert Opin Ther Targets. 2019. PMID: 30556751 Review.
Downregulation of A2AR by siRNA loaded PEG-chitosan-lactate nanoparticles restores the T cell mediated anti-tumor responses through blockage of PKA/CREB signaling pathway.
Masjedi A, Hassannia H, Atyabi F, Rastegari A, Hojjat-Farsangi M, Namdar A, Soleimanpour H, Azizi G, Nikkhoo A, Ghalamfarsa G, Mirshafiey A, Jadidi-Niaragh F. Masjedi A, et al. Int J Biol Macromol. 2019 Jul 15;133:436-445. doi: 10.1016/j.ijbiomac.2019.03.223. Epub 2019 Mar 30. Int J Biol Macromol. 2019. PMID: 30936011
Blockage of immune checkpoint molecules increases T-cell priming potential of dendritic cell vaccine.
Hassannia H, Ghasemi Chaleshtari M, Atyabi F, Nosouhian M, Masjedi A, Hojjat-Farsangi M, Namdar A, Azizi G, Mohammadi H, Ghalamfarsa G, Sabz G, Hasanzadeh S, Yousefi M, Jadidi-Niaragh F. Hassannia H, et al. Among authors: masjedi a. Immunology. 2020 Jan;159(1):75-87. doi: 10.1111/imm.13126. Epub 2019 Oct 24. Immunology. 2020. PMID: 31587253 Free PMC article.
Regulatory T cells in breast cancer as a potent anti-cancer therapeutic target.
Hashemi V, Maleki LA, Esmaily M, Masjedi A, Ghalamfarsa G, Namdar A, Yousefi M, Yousefi B, Jadidi-Niaragh F. Hashemi V, et al. Among authors: masjedi a. Int Immunopharmacol. 2020 Jan;78:106087. doi: 10.1016/j.intimp.2019.106087. Epub 2019 Dec 13. Int Immunopharmacol. 2020. PMID: 31841758 Review.
Silencing of IL-6 and STAT3 by siRNA loaded hyaluronate-N,N,N-trimethyl chitosan nanoparticles potently reduces cancer cell progression.
Masjedi A, Ahmadi A, Atyabi F, Farhadi S, Irandoust M, Khazaei-Poul Y, Ghasemi Chaleshtari M, Edalati Fathabad M, Baghaei M, Haghnavaz N, Baradaran B, Hojjat-Farsangi M, Ghalamfarsa G, Sabz G, Hasanzadeh S, Jadidi-Niaragh F. Masjedi A, et al. Int J Biol Macromol. 2020 Apr 15;149:487-500. doi: 10.1016/j.ijbiomac.2020.01.273. Epub 2020 Jan 28. Int J Biol Macromol. 2020. PMID: 32004600
45 results